文献速递心境障碍

优化多通道4mA对比传统经颅直流电刺激治疗重性抑郁障碍:随机假对照试验

Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial.
PubMed 文献 · Mol Psychiatry · 2026-04-02

该随机假对照试验比较计算优化的多通道tDCS(4mA)与传统tDCS(2mA)治疗单相抑郁的疗效。两种活性tDCS均显著减轻抑郁症状,多通道组起效更早、症状缓解更强,并改善认知控制与功能连接。

要点

  • 优化多通道4mA tDCS在减轻抑郁症状上起效更早、效果更强于传统2mA tDCS。
  • 多通道tDCS还改善认知控制并调节与抑郁病理相关的功能连接标志物。
  • 多通道组盲法未成功,可能与刺激相关感觉更强烈有关,但未影响临床结局。

核心结论

  • 优化多通道4mA tDCS对治疗抑郁显示临床疗效,值得未来进一步研究。

主要发现

  • 干预后两种活性tDCS均较假组显著减轻抑郁症状,多通道tDCS比传统tDCS起效更早且症状缓解更强。
  • 主要临床结局从基线至研究终点的平均变化:假组6.30,传统tDCS组13.50,多通道tDCS组21.50。
  • 对应应答率(症状减轻≥50%):假组20%(4/20),传统tDCS组45%(9/20),多通道tDCS组75%(15/20)。
  • 多通道tDCS还改善认知控制并调节与抑郁病理生理相关的功能连接标志物。
  • 盲法仅在优化多通道组未成功,可能因刺激相关感觉更强烈,但未影响临床结局。

关键数值与推荐

  • 优化多通道tDCS通过7个小电极输送电流(每电极最大1.65mA;每极性总注入电流约4mA,精确为3.99mA)。
  • 传统tDCS每电极2mA,使用两个35cm²海绵电极;假tDCS同样使用两个35cm²海绵电极。
  • 疗效与治疗应答在干预前、第2、4、6周及干预后1个月和3个月评估;认知功能与脑连接在干预前后评估。

临床怎么用

  • 优化多通道4mA tDCS可作为重性抑郁障碍的潜在治疗选择,但需进一步研究验证。
  • 临床选用多通道tDCS时需注意刺激相关感觉更强烈可能影响盲法,但本研究中未影响临床结局。

局限性

  • 优化多通道组盲法未成功,可能因刺激相关感觉更强烈。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Major depressive disorder is a prevalent mental condition and the second most disabling disease. Transcranial direct current stimulation (tDCS), with advantages such as affordability, home-use application, and mild side effects, has been proposed for treating depression. Yet, its clinical efficacy is not established. Optimizing tDCS interventions for more effective and feasible clinical application is a need and topic of ongoing research. This randomized, sham‑controlled trial compares the efficacy of computationally optimized multichannel tDCS (4 mA), a less source-demanding alternative for personalized tDCS, vs conventional tDCS (2 mA) for treating unipolar depression. Seventy-one patients were randomly assigned to the optimized multichannel tDCS, conventional tDCS, and sham tDCS arms, of whom 60 provided endpoint data. In the optimized multichannel tDCS, electrical current was delivered via 7 small electrodes (max 1.65 mA per electrode; total injected current per polarity ≈ 4 mA [precisely 3.99 mA]) while in the conventional (2 mA per electrode) and sham tDCS, two 35 cm² sponge electrodes were used. Intervention efficacy and treatment response were evaluated before the intervention, at weeks 2, 4, 6, and 1- and 3-month post-intervention, and cognitive functions and brain connectivity changes were assessed before and after the intervention. Both active tDCS interventions significantly reduced depressive symptoms compared to the sham group after the intervention. The optimized multichannel tDCS demonstrated earlier and stronger symptom alleviation than conventional tDCS. It additionally improved cognitive control and modulated functional connectivity markers associated with depression pathophysiology. The mean change in the primary clinical outcome from baseline to the study endpoint was 6.30 in the sham group and 13.50 and 21.50 in the conventional and multichannel tDCS groups, with corresponding response rate (≥50% symptom reduction) of 20% (4/20), 45% (9/20), and 75% (15/20), respectively. Blinding was unsuccessful only in the optimized multichannel arm, likely due to more intense stimulation-related sensations, however, this did not impact clinical outcomes. The optimized multichannel 4 mA tDCS shows clinical efficacy for treating depression, warranting further investigations in the future. Trial Registration Identifier: NCT06165445 / IRCT20210517051330N1.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Salehinejad MA, Abdi M, Dadashi M, et al. Optimized multichannel 4 mA vs conventional transcranial direct current stimulation for major depressive disorder: A randomized sham-controlled trial. Mol Psychiatry. 2026. PMID: 41927768. doi:10.1038/s41380-026-03560-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。